Nanodiagnostics and Nanotherapeutics for age-related macular degeneration

This publication has 131 references indexed in Scilit:

• Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
  ACS Nano, 2013
• Liposomes and nanotechnology in drug development: focus on ocular targets
  International Journal of Nanomedicine, 2013
• Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
  International Journal of Nanomedicine, 2011
• Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization
  PLOS ONE, 2011
• The potential of nanomedicine therapies to treat neovascular disease in the retina
  Journal of Angiogenesis Research, 2010
• Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy
  Investigative Ophthalmology & Visual Science, 2009
• Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV
  Gene Therapy, 2009
• Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
  Journal of Controlled Release, 2008
• Recent progress in macular function self‐assessment
  Ophthalmic and Physiological Optics, 2008
• Ophthalmic light sensitive nanocarrier systems
  Drug Discovery Today, 2008